IL2 and acute myeloid leukemia: Similarly, in an in vivo model of AML, transient depletion of Tregs using IL-2-diphtheria toxin (IL-2DT) resulted in reduced AML tumor burden and improved the proliferation of adoptively-transferred tumor-reactive cytotoxic T-lymphocytes (CTLs) (83).